Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) is a special purpose acquisition company (SPAC) dedicated to merging with and advancing transformative enterprises in the life sciences arena. Backed by a seasoned management team with extensive industry experience, OACCU seeks to address pressing healthcare challenges across pharmaceuticals, biotechnology, and medical technology sectors. Positioned to capitalize on the rapidly evolving landscape of life sciences, OACCU is committed to generating shareholder value through strategic investments that foster innovation, enhance patient outcomes, and refine health management solutions.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.29 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.46M |
| % Insiders | 3.04% |
| % Institutions | 15.14% |
Volatility is currently expanding